Sharechat Logo

Rua announces closing date for Director Nominations 2022

Tuesday 23rd August 2022

Text too small?

Rua Bioscience Limited (NZX: RUA ) advises the closing date for Director nominations is 5:00pm NZST on Tuesday 6 September 2022.

Nominations may only be made by a shareholder entitled to attend and vote at the meeting, and be accompanied by the consent in writing of the person nominated.

Any nominations should be emailed to:

Hamish.white@ruabio.com

Or addressed to:

Director Nominations

Attn: Hamish White

CFO and Company Secretary

Rua Bioscience

PO Box 1387

Gisborne, 4040

Rua takes this opportunity to remind Shareholders that its 2022 Annual Meeting will be held at 10:00am (New Zealand time) on 12 October 2022. The meeting will be a hybrid meeting hosted at Waikanae Surf Club, Grey St, Gisborne and supported by a virtual meeting platform.

Further details for participation and voting online will be included in the formal Notice of Annual Shareholders’ Meeting which will be released prior to the meeting.

ENDS

2022 Director Nominations and Annual Meeting Announcement



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved